pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON
Disc Medicine
Disc Medicine clinical programs — 103 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
- Employees
- 165
- Programs
- 308
- Drugs
- 442
- Patents
- 706
Disc Medicine projects
103 ClinicalTrials.gov programs sponsored by Disc Medicine.
Disc Medicine has 103 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
V0001699
Disc Medicine
Oral cancer
1 trial -
VENLAFAXINE
Disc Medicine
Major Depressive Disorder
1 trial -
Vaxigrip Tetra for healthy individuals
Disc Medicine
healthy individuals
1 trial -
XELJANZ 11 mg prolonged-release tablets
Disc Medicine
Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criteria
1 trial -
[68Ga]FAPI-46
Disc Medicine
Non-resolving ARDS
1 trial -
[68Ga]FAPI-46
Disc Medicine
post-acute sequelae of COVID-19
1 trial -
[68Ga]FAPI-46
Disc Medicine
Peyronie's Disease
1 trial
Frequently asked questions
How many clinical projects does Disc Medicine have?
103 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.